Pyxis Oncology, Inc. — Investor Relations & Filings
Pyxis Oncology, Inc. is a clinical-stage company focused on developing next-generation therapeutics for difficult-to-treat cancers. The company's differentiated portfolio of clinical assets is centered on two primary modalities: antibody-drug conjugates (ADCs) and immuno-oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for enhanced safety and efficacy. The immuno-oncology programs utilize monoclonal antibodies (mAbs) to mobilize the body's immune system to attack cancer cells by blocking tumor defense mechanisms and overcoming immune suppression. Pyxis Oncology is advancing its product candidates as both monotherapies and in combination with other therapies to improve outcomes for patients with solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45988994 | 10-Q | 2026-05-14 | English | ||
| 45977153 | 8-K | 2026-05-14 | English | ||
| 39075634 | ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39073772 | DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39069707 | 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 33043094 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33043082 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33042858 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33012784 | 10-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 33012771 | 8-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 31693671 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
| 31693670 | 8-K Filing | 2026-02-06 | English | ||
| 31693678 | 4 Filing | 2026-02-05 | English | ||
|
2025
2 filings
| |||||
| 13190750 | 8-K | 2025-12-18 | English | ||
| 13190751 | Regulatory Filings 2025 | 2025-12-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD
Produces injections, solid dosage forms, APIs, and nutritio…
|
000153 | CN | Manufacturing |
|
Anhui Huangshan Capsule Co.,Ltd
Produces empty hard capsules, including gelatin and HPMC ve…
|
002817 | CN | Manufacturing |
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
Develops and manufactures pharmaceutical excipients for sol…
|
300452 | CN | Manufacturing |
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
Pyxis Oncology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33976/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33976 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33976 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33976 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33976}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pyxis Oncology, Inc. (id: 33976)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.